Pharmaceuticals & Life Sciences Articles & Blogs

Government Boosts UK Life Sciences with £650m 'Life Sci' Package

Friday, 05 May 2023

The Government has given UK life sciences a boost with a £650 million multi-faceted package of 'Life Sci for Growth' measures - recognising the importance of an industry worth over £94 billion and employing more than 280,000 in the UK.

Government Boosts UK Life Sciences with £650m 'Life Sci' Package

Articles & Blogs Pharma & Life Sciences

Parliament Debate Calls for New Approach to VPAS to Protect UK Life Sciences

Monday, 22 May 2023

A Parliament debate has called for a new approach to the Voluntary Pricing and Access Scheme (VPAS) if the UK is to be seen as an attractive place for life sciences.

Parliament Debate Calls for New Approach to VPAS to Protect UK Life Sciences

Articles & Blogs Pharma & Life Sciences

EU Pharma Reforms - What Now, and What Next?

Wednesday, 10 May 2023

EU proposes new legislative acts to update and streamline pharma legislation.

EU Pharma Reforms - What Now, and What Next?

Pharma & Life Sciences

What We Can Learn from the Advanced Purchasing of COVID-19 Vaccines

Wednesday, 10 May 2023

Post COVID-19's downgrading from a public health emergency of international concern, now is a good time to reflect on considerations for large supply and manufacturing agreements.

What We Can Learn from the Advanced Purchasing of COVID-19 Vaccines

Articles & Blogs Pharma & Life Sciences

BGMA Seeks Judicial Review to Be Involved in New VPAS Negotiations Alongside ABPI

Thursday, 04 May 2023

The body representing suppliers of UK generic and biosimilar medicines is taking legal action to be more involved in negotiating the next rebate deal, which the pharma industry has seen as an unfair additional tax that doesn't apply to other industries.

BGMA Seeks Judicial Review to Be Involved in New VPAS Negotiations Alongside ABPI

Supreme Court Refuses to Add Terms When Contract Was Silent

Wednesday, 12 April 2023

What happens when a commercial contract provides for one party to be remunerated in one situation, but not in another? Would the courts imply an additional right to remuneration?

Supreme Court Refuses to Add Terms When Contract Was Silent

Articles & Blogs Pharma & Life Sciences

Super Times for Clinical Trials in the UK

Wednesday, 12 April 2023

The very established practices of ethical human experimentation are changing, partly, due to related new methods forged in the fire of a terrible pandemic, and partly to long-held ambitions made reality by technological advances.

Super Times for Clinical Trials in the UK

Articles & Blogs Pharma & Life Sciences

New Specialist Life Sciences College Opens in Stevenage

Monday, 27 March 2023

The Stevenage Innovation & Technology Centre (SITEC) has officially opened. SITEC has specialist life sciences facilities, designed to provide practical training for students to get ready for the life sciences jobs of the future.

New Specialist Life Sciences College Opens in Stevenage

Articles & Blogs Pharma & Life Sciences

PMCPA Release Social Media to Adhere with ABPI Code

Tuesday, 21 March 2023

The Prescription Medicines Code of Practice Authority (PMCPA) has released guidance on social media advertisement for pharma suppliers, which goes into detail on particular topics.

PMCPA Release Social Media to Adhere with ABPI Code

Articles & Blogs Pharma & Life Sciences

Protein That Aids Skin Cancer Spread Discovered

Tuesday, 21 March 2023

Researchers have identified a protein which assists the spread of skin cancer to different systems in the body.

Protein That Aids Skin Cancer Spread Discovered

Articles & Blogs Pharma & Life Sciences

Decentralised Medicine Manufacturing Is Getting Closer

Tuesday, 07 March 2023

There are some major challenges, but the new world of Point of Care (POC) manufacturing comes with exciting prospects for innovators, suppliers and patients.

Decentralised Medicine Manufacturing Is Getting Closer

Articles & Blogs Pharma & Life Sciences

UK Pharma at Crossroads as New Medicines Deal Needed for Pharma and Patients - ABPI

Tuesday, 07 March 2023

UK pharma is at a crossroads and a new medicines deal is needed, for patients, the NHS and the economy.

UK Pharma at Crossroads as New Medicines Deal Needed for Pharma and Patients - ABPI

Articles & Blogs Pharma & Life Sciences

Windsor Framework - The Start of a Brighter EU-UK Life Sciences Future?

Wednesday, 01 March 2023

It would be safe to say that relations between the UK and EU have not been as positive as they could have been since 23 June 2016. This has been particularly felt in pharma and life sciences. Now, with the Windsor Framework, are things going to change?

Windsor Framework - The Start of a Brighter EU-UK Life Sciences Future?

Articles & Blogs Pharma & Life Sciences

Collaboration - Being Prepared and Avoiding the Pitfalls

Thursday, 16 February 2023

This article summarises some key observations from a legal perspective which, based on our experience, we would recommend are considered carefully before launching into any collaborative arrangement.

Collaboration - Being Prepared and Avoiding the Pitfalls

Articles & Blogs Pharma & Life Sciences

UK Pharma Pricing in Crisis

Thursday, 16 February 2023

The UK pharma pricing scheme - the Voluntary Scheme for Branded Medicines Pricing and Access (known as VPAS) is in crisis, and it must change in the new pricing deal from 2024 onwards in order for the UK to be an attractive place for life sciences.

Pharma & Life Sciences

Share this page: